vs
Galecto, Inc.（GLTO）与阿帕奇（LASE）财务数据对比。点击上方公司名可切换其他公司
Galecto, Inc.的季度营收约是阿帕奇的1.1倍（$1.0M vs $919.3K），阿帕奇净利率更高（-506.4% vs -20053.5%，领先19547.1%），Galecto, Inc.同比增速更快（339.0% vs 28.3%），过去两年Galecto, Inc.的营收复合增速更高（50.5% vs -3.9%）
Galecto是一家生物科技公司，专注研发针对重症治疗的小分子药物，覆盖纤维化、癌症与炎症等治疗领域。公司由来自瑞典、英国、丹麦的半乳糖凝集素研究权威与生物科技行业高管于2011年创立，目前注册地位于美国，运营总部设在丹麦哥本哈根。
IPG光子公司是光纤激光器制造商，研发并商业化推广光纤激光器产品，其产品广泛应用于材料加工、医疗、电信等多个领域，目前在美国、德国、俄罗斯和意大利均设有生产基地。
GLTO vs LASE — 直观对比
营收规模更大
GLTO
是对方的1.1倍
$919.3K
营收增速更快
GLTO
高出310.8%
28.3%
净利率更高
LASE
高出19547.1%
-20053.5%
两年增速更快
GLTO
近两年复合增速
-3.9%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0M | $919.3K |
| 净利润 | $-200.7M | $-4.7M |
| 毛利率 | — | -20.1% |
| 营业利润率 | -20149.5% | -350.0% |
| 净利率 | -20053.5% | -506.4% |
| 营收同比 | 339.0% | 28.3% |
| 净利润同比 | -2877.8% | -186.5% |
| 每股收益（稀释后） | $10.86 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLTOLASE
| Q4 25 | $1.0M | — | ||
| Q3 25 | — | $919.3K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $228.0K | $1.3M | ||
| Q3 24 | $146.0K | $716.7K | ||
| Q2 24 | $213.0K | $623.4K | ||
| Q1 24 | $257.0K | $743.0K |
净利润GLTOLASE
| Q4 25 | $-200.7M | — | ||
| Q3 25 | — | $-4.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | $-6.7M | $586.4K | ||
| Q3 24 | $-3.9M | $-1.6M | ||
| Q2 24 | $-5.3M | $-934.3K | ||
| Q1 24 | $-5.5M | $-545.7K |
毛利率GLTOLASE
| Q4 25 | — | — | ||
| Q3 25 | — | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | — | 13.3% | ||
| Q3 24 | — | 85.0% | ||
| Q2 24 | — | 50.6% | ||
| Q1 24 | — | 51.9% |
营业利润率GLTOLASE
| Q4 25 | -20149.5% | — | ||
| Q3 25 | — | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | -3114.9% | -255.1% | ||
| Q3 24 | -2630.1% | -238.0% | ||
| Q2 24 | -2618.3% | -149.4% | ||
| Q1 24 | -2233.9% | -73.8% |
净利率GLTOLASE
| Q4 25 | -20053.5% | — | ||
| Q3 25 | — | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | — | -73.4% | ||
| Q4 24 | -2956.6% | 45.7% | ||
| Q3 24 | -2659.6% | -226.8% | ||
| Q2 24 | -2506.1% | -149.9% | ||
| Q1 24 | -2131.1% | -73.4% |
每股收益（稀释后）GLTOLASE
| Q4 25 | $10.86 | — | ||
| Q3 25 | — | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | $-5.17 | $0.06 | ||
| Q3 24 | $-3.39 | $-0.13 | ||
| Q2 24 | $-4.92 | $-0.09 | ||
| Q1 24 | $-5.05 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.6M | $3.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $240.4M | $4.1M |
| 总资产 | $260.5M | $17.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLTOLASE
| Q4 25 | $257.6M | — | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $78.5K | ||
| Q1 25 | — | $179.1K | ||
| Q4 24 | $14.2M | $533.9K | ||
| Q3 24 | $19.7M | $2.1M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | $27.2M | $5.2M |
股东权益GLTOLASE
| Q4 25 | $240.4M | — | ||
| Q3 25 | — | $4.1M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | $15.8M | $10.2M | ||
| Q3 24 | $20.9M | $9.7M | ||
| Q2 24 | $23.6M | $10.3M | ||
| Q1 24 | $28.2M | $12.4M |
总资产GLTOLASE
| Q4 25 | $260.5M | — | ||
| Q3 25 | — | $17.5M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | $17.1M | $17.2M | ||
| Q3 24 | $23.4M | $10.6M | ||
| Q2 24 | — | $11.1M | ||
| Q1 24 | $32.5M | $13.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $566.0K | $763.1K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GLTOLASE
| Q4 25 | $566.0K | — | ||
| Q3 25 | — | $763.1K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | $-4.9M | $-6.5M | ||
| Q3 24 | $-3.7M | $632.7K | ||
| Q2 24 | $-4.1M | $-2.4M | ||
| Q1 24 | $-5.9M | $-866.3K |
自由现金流GLTOLASE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M |
自由现金流率GLTOLASE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% |
资本支出强度GLTOLASE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% |
现金转化率GLTOLASE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
